$1.01
-0.04-3.81%
At close: Aug 14, 5:00 PM EST
$1.02
0.00990.98%
After Hours: 7:17 PM EST
ADC Therapeutics SA
ADCTNYSE
Earnings: Q2 2026 Earnings were released on Thu Aug 13th, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 2 days agoClick to view the webcast
ADC Therapeutics Earnings & Forecasts
ADC Therapeutics (ADCT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ADC Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.21 | $-0.20 | $-0.29 | $-0.38 |
| Actual | $-0.11 | $-0.13 | $-0.09 | $-0.19 |
| Surprise | +47.6% | +35.0% | +69.0% | +50.0% |
| Revenue | ||||
| Estimate | $19.1M | $19.9M | $21.0M | $16.5M |
| Actual | $19.2M | $20.9M | $23.1M | $16.4M |
| Surprise | +0.53% | +4.58% | +9.61% | -0.54% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.21 | $-0.21 |
| Revenue | ||
| Consensus | $19.2M | $22.3M |
